Blood analyzers to be qualified for spaceflight by NASA’s Commercial-Off-The Shelf (COTS) certification process
CAMBRIDGE, Mass., September 30, 2019 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., today announced that rHEALTH ONE blood analyzers have been delivered to NASA and its prime contractor Zin Technologies for spaceflight qualification. The technology will undergo a rigorous...
Read more
Abstracts for rHEALTH’s Factor VIII and Platelet Tests Accepted for Poster and Oral Presentations at Upcoming AACC 2019 Meeting
rHEALTH tests to be presented at the industry’s leading annual conference for laboratory medicine
CAMBRIDGE, Mass., July 11, 2019 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., today announced that both of its abstracts have been accepted via peer-review from for the 2019 American Association of Clinical Chemistry (AACC) meeting. The titles and details...
Read more
rHEALTH Nanostrips, Vitals Device, and Fluidics Module to Receive U.S. Patent Protection
rHEALTH Nanostrips, Vitals Device, and Fluidics Module to Receive U.S. Patent Protection. Expands patent protection for diagnose yourself, anywhere technology
CAMBRIDGE, Mass., May 21, 2019 -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, today announced that three separate aspects of its technology platform has received a Notice of Allowance and two Issue Notifications from the...
Read more
rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes
rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes
This patent enables rHEALTH’s unique technology to measure many analytes in a given small volume sample at home or in the clinic
CAMBRIDGE, Mass., January 23, 2019 /PRWeb/ -- rHEALTH LLC, an innovative digital health solutions company, announced today that...
Read more